Abiopharma

Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual Meeting

New Form 144 - Apellis Pharmaceuticals, Inc. Filed: 2025-09-08 AccNo: 0001959173-25-005819 Size: 6 KB

New Form 8-K - Coherus Oncology, Inc. Filed: 2025-09-08 AccNo: 0001558370-25-011911 Size: 158 KB Item 8.01: Other Events

New Form F-3/A - Prenetics Global Ltd Filed: 2025-09-08 AccNo: 0001876431-25-000003 Size: 837 KB

New Form 8-K - ETHZilla Corp Filed: 2025-09-08 AccNo: 0001213900-25-085321 Size: 627 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item …

Ainos to Showcase AI Nose at SEMICON Taiwan 2025

New Form 8-K - FOXO TECHNOLOGIES INC. Filed: 2025-09-08 AccNo: 0001641172-25-026820 Size: 202 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form 8-K - CASSAVA SCIENCES INC Filed: 2025-09-08 AccNo: 0001437749-25-028530 Size: 6 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

GE HealthCare Enters an Agreement to Distribute Flyrcado Through CDL Nuclear Technologies Group, a Leading Provider of Cardiac PET Imaging Equipment and Services in the U.S.

TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

- Femasys Secures Regulatory Approval for FemBloc®Permanent Birth Control in New Zealand

New Form SCHEDULE 13G - electroCore, Inc. Filed: 2025-09-08 AccNo: 0002058477-25-000002 Size: 9 KB

New 4-Year Data for Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Presented at ICIEM

New Form 8-K - Ainos, Inc. Filed: 2025-09-08 AccNo: 0001493152-25-012781 Size: 293 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

MediciNova Provides Shareholder Update on Key Developments